Graduate Partnership Program Logo
 
  
 
Site Index  |  FAQs
 Back to home Picture collage of Students

 
 
 
 
   
   
 
 


Faculty

Buonanno, Andres

DR  ANDRES L BUONANNO
Ph.D., Washington University, 1987
National Institutes of Health
NICHD DIR LCSN SMN

35 LINCOLN DRIVE
BLDG 35 RM 2C1000 MCS 3713
BETHESDA MD 20892-3713

Phone:  +1 301 496 0170
Fax:  +1 301 480 2707
Email:  buonanno@mail.nih.gov
Web:  http://dir.nichd.nih.gov/LDN_Labs/BuonannoLab/Buonanno.html

GPP Logo here

Research Interest(s):
Neuroscience & Degenerative Diseases
Developmental Biology / Reproduction
Psychology & Behavioral Sciences
Genetics & Human Genome

Research Description:
Regulation of Neuronal Plasticity by the Neuregulin/ErbB Signaling Pathway: Implications for Neurological Disorders

Dr. Buonanno's laboratory has a general interest in investigating molecular pathways that regulate neuronal plasticity, and that may contribute to understanding complex processes such as behavior and neurological disease. Studies in his laboratory have focused on the Neuregulin (NRG) family of trophic and differentiation factors, which have been shown to modulate neuronal development, synaptic plasticity and behavior. Recent genetic linkage studies with Finish and Irish families have implicated NRGs, and their receptors (ErbB 1-4), with the neurological disorder schizophrenia. Results obtained using knock-out mice for either NRG or the ErbB-4 receptor are consistent with the idea that this signaling pathway, which modulates glutamatergic neurotransmission via NMDA receptors, contributes to behaviors associated with this neurological disorder. Previous work from this laboratory demonstrated that co-activation of NMDA and ErbB receptors modifies glutamate receptor subunit expression during neuronal development (Nature 390: 691-694 [1997]). Later work demonstrated that the c-termini of ErbB-4 receptors, like those of NMDA receptors, interact with PSD-95 in a yeast two-hybrid screen. Immunoprecipitation and Immunofluorescence studies showed that NMDA and ErbB receptors form a ternary complex at excitatory glutamatergic synapses (PNAS 97:3596-3601[2000]). These findings are important because PSD-95 is a protein characterized by multiple PDZ-type protein-protein interaction domains that physically couples the entry of calcium through NMDA receptors, to the activation of signaling proteins on the postsynaptic side that modify synaptic plasticity. Moreover, tyrosine phosphorylation modifies the electrophysiological properties and trafficking of NMDA receptors at synapses, an important issue considering that NMDA receptor activity has been implicated by numerous studies to synaptic plasticity (induction of LTP) and to schizophrenia. We are utilizing knock-out mice for different members of the NRG/ErbB signaling pathway, as well as molecular, biochemical and electrophysiological studies, to understand the precise role of this pathway in synaptic plasticity and neurological disease.

Selected Publications:

Ozaki, M., Sasner, M., Yano, R., Lu, H.S. and Buonanno, A. (1997) Neuregulin stimulates NMDA receptor gene expression in cerebellar neurons. Nature 390, 691-694.

Garcia, R., Vasudevan, K., and Buonanno, A. (2000) The neuregulin receptor ErbB-4 interacts with the PDZ domain protein at neuronal synapses. Proc. Natl. Acad. Sci. USA . 97, 3596-3601.

Buonanno, A. and Fischbach, G. (2001) Neuregulin and ErbB receptor signalling in the Nervous System. Current Opinions in Neurobiol 11, 287-296.